Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fast-onset antidepressants

S A Montgomery1

  • 1Department of Pharmacology, Imperial College of Medicine, St Mary's Hospital, London, UK.

International Clinical Psychopharmacology
|July 1, 1997
PubMed
Summary
This summary is machine-generated.

Researchers are developing fast-acting antidepressants to speed up treatment response. New methods help identify these rapid-response drugs, potentially offering significant relief, though their exact speed remains under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intermittent At-Home Suctioning of Esophageal Content for Prevention of Recurrent Aspiration Pneumonia in 4 Dogs with Megaesophagus.

Journal of veterinary internal medicine·2016
Same author

Identification of candidate genes for chicken early- and late-feathering.

Poultry science·2016
Same author

Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Prophylaxis in recurrent unipolar depression: a new indication for treatment studies.

Journal of psychopharmacology (Oxford, England)·2011
Same author

Clinical measures of rapid onset of action.

European psychiatry : the journal of the Association of European Psychiatrists·2009
Same author

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.

International journal of clinical practice·2008

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Psychiatry

Background:

  • Antidepressant treatment response is often slow.
  • There is a growing need for faster-acting therapeutic options.
  • Current antidepressants can take weeks to show effects.

Purpose of the Study:

  • To explore the potential of fast-acting antidepressants.
  • To highlight advances in identifying rapid-response antidepressant medications.
  • To discuss the future implications of these developments.

Main Methods:

  • Development of novel methodologies for antidepressant screening.
  • Focus on identifying drugs with accelerated onset of action.
  • Emphasis on rigorous study design for validation.

Related Experiment Videos

Main Results:

  • Methodology for identifying rapid-response antidepressants has been developed.
  • These fast-acting antidepressants show promise for future clinical use.
  • The precise speed of action for these novel drugs requires further clarification.

Conclusions:

  • Fast-acting antidepressants represent a significant potential advance in mental health treatment.
  • Further well-conducted studies are essential to confirm the efficacy and speed of these new drugs.
  • These medications could offer substantial relief to individuals with depression and the wider community.